These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4134002)

  • 21. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
    Narcisi EM; Secor WE
    Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors.
    Petmitr PC; Ramdja M; Kajorndechakiat S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.
    Hrdý I; Cammack R; Stopka P; Kulda J; Tachezy J
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5033-6. PubMed ID: 16304169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
    Soffar SA; Metwali DM; Abdel-Aziz SS; el-Wakil HS; Saad GA
    J Egypt Soc Parasitol; 2001 Dec; 31(3):893-904 + 1p plate. PubMed ID: 11775115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro effect of tinidazole in Trichomonas vaginalis and Trichomonas hominis].
    Huang MY; Lian WN
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1987; 5(1):29-31. PubMed ID: 3497735
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of Cladonia alpestris on Trichomonas vaginalis in vitro].
    Wu J; Zhang M; Ding D; Tan T; Yan B
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):126-9. PubMed ID: 7554162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of antimicrobial nitroimidazolyl 2-sulfides, -sulfoxides, and -sulfones.
    Tweit RC; Kreider EM; Muir RD
    J Med Chem; 1973 Oct; 16(10):1161-9. PubMed ID: 4201423
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents.
    Lövgren T; Salmela I
    Acta Pathol Microbiol Scand B; 1978 Jun; 86B(3):155-8. PubMed ID: 102108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.
    Korner B; Jensen HK
    Br J Vener Dis; 1976 Dec; 52(6):404-8. PubMed ID: 1087577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.
    Meingassner JG; Thurner J
    Antimicrob Agents Chemother; 1979 Feb; 15(2):254-7. PubMed ID: 311617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the velocity of action of trichomonocidal drugs].
    Broccali G; De Carneri I
    Ginecol Obstet Mex; 1971 Nov; 30(181):481-90. PubMed ID: 5316160
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo and in vitro studies of tinidazole in Trichomonas vaginalis infection.
    Sucharit P; Uthaischant A; Chintana T; Suphadtanapongs W; Eamsobhana P; Prasomsitti P
    Southeast Asian J Trop Med Public Health; 1979 Dec; 10(4):556-61. PubMed ID: 317171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Trichomonacidal activity of newly synthesized derivatives of benzoizothiazolinon (BIT) in vitro].
    Ziomko I; Kuczyńska E
    Wiad Parazytol; 1994; 40(1):59-64. PubMed ID: 8023507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physical-chemical properties and antitrichomonal effect of 2-, 4-, and 5-nitroimidazoles].
    Sunjić V; Kajfez F; Kolbah D; Blazević N
    Pharmazie; 1972 Mar; 27(3):131-8. PubMed ID: 4558978
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
    Giordani RB; De Almeida MV; Fernandes E; França da Costa C; De Carli GA; Tasca T; Zuanazzi JA
    Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Setting a colorimetric assay with MTT for assessment of trichomonicidal activity.
    Sariego I; Monzote L; Rojas L
    Curr Clin Pharmacol; 2014; 9(3):283-7. PubMed ID: 23173972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro studies on the identification of metronidazole resistant strains of Trichomonas vaginalis (author's transl)].
    Meingassner JG; Stockinger K
    Z Hautkr; 1981 Jan; 56(1):7-15. PubMed ID: 6971538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.